Corticosteroids With Vedolizumab in Crohn's Disease

Summary

Use of co-induction with corticosteroid therapies may accelerate the remission rate when used with vedolizumab. Further, this may lead to higher rates of response and remission at week 10 than would be seen with vedolizumab monotherapy.

Timeline

Start

2016-04

Primary completion

2018-02-08

Completion

2018-02-08

Outcome

Outcome not reported

Stopped (Enrollment): “Difficult recruitment”

Drugs

Indications